Molecular Pathways: The Balance Between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor- B Signaling for Cancer Treatment

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-15-1374
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Targeting Nuclear Factor Kappa B for the Treatment of Prostate Cancer

2005English

Molecular Pathways: Targeting P21-Activated Kinase 1 Signaling in Cancer--Opportunities, Challenges, and Limitations

Clinical Cancer Research
Cancer ResearchOncology
2012English

Targeting Core Signaling Pathways in Pancreatic Cancer

Science-Business eXchange
2008English

Molecular Pathways and Therapeutic Targets in Lung Cancer

Oncotarget
Oncology
2014English

Molecular Pathways: Targeting Resistance in the Androgen Receptor for Therapeutic Benefit

Clinical Cancer Research
Cancer ResearchOncology
2013English

Signaling Pathways in Thyroid Cancer and Their Therapeutic Implications

Journal of Clinical Medicine Research
2016English

“Targeting the Absence” and Therapeutic Engineering for Cancer Therapy

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2008English

The Role of the Transcription Factor Nuclear Factor-Kappa B in Thyroid Autoimmunity and Cancer

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2018English

Two Birds With One Stone: Therapeutic Targeting of IL1α Signaling Pathways in Pancreatic Ductal Adenocarcinoma and the Cancer-Associated Fibroblasts

Cancer Discovery
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy